Clinical trial
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and…
NCT00435370 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00435370 |
|---|---|
| Title | Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia |
| Official title | Tropisetron With Risperidone for Schizophrenia |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation, Schizophrenia |
| Intervention type | Drug |
| Interventions | Tropisetron, Placebo, Risperidone |
| Enrollment | 179 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Feb 14, 2007 |
| Last update posted | Mar 15, 2017 |
| Countries | China, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: